Fibrinogen in hemodialysis: the worst of both worlds?
T. Goodship
DOI: https://doi.org/10.1046/J.1523-1755.2003.00748.X
IF: 19.6
Kidney International
Abstract:Fibrinogen is synthesized in hepatocytes as three polypeptide chains (A, B, and ). The genes for these three proteins are closely linked on chromosome 4q. Fibrinogen is secreted as a dimer with each polypeptide represented twice and a wide normal range for serum fibrinogen concentration (150 to 350 mg/L). Cleavage of the N-terminal region of each A chain by thrombin starts fibrin polymerization. Fibrinogen and fibrin not only play a key role in coagulation but are also involved in cellular interactions, wound healing, and neoplasia. Numerous other proteins, including fibroblast growth factor–2 (FGF-2) and insulin-like growth factor-1 (IGF-1) bind to fibrinogen and fibrin. Serum fibrinogen concentration is an independent risk factor for ischemic heart disease. A meta-analysis of 18 studies showed that, even after adjustment for confounders such as age and smoking, there was a risk ratio of 1.8 for those subjects with a serum fibrinogen concentration in the top one third compared to the bottom third1. Although there are biological reasons why this relationship might be causal, prospective trials of fibrinogen reduction are needed to establish this. Many factors are known to affect plasma fibrinogen levels, including diet, drugs, age, smoking, alcohol, body mass, sex, exercise and race2. In addition, twin studies show that there is a significant genetic component. Polymorphisms in the fibrinogen B chain are associated with levels of fibrinogen but not the risk of ischemic heart disease. In patients with chronic renal failure, fibrinogen levels are substantially elevated and as in the normal population are associated with an increased cardiovascular risk. The study by Kaysen et al of 74 hemodialysis patients enrolled in the HEMO study has shown some of the factors that may determine this3. Albumin synthesis had previously been measured and reported in 64 of these patients4. It was found that serum albumin concentration correlated with its synthesis rate and the normalized protein catabolic rate. Albumin synthesis rates in turn correlated with plasma volume and body mass index. In the current study, the relationship between fibrinogen levels and albumin synthesis, plasma volume, and levels of acute phase proteins was examined. Fibrinogen levels were very high and correlated positively with albumin synthesis, C-reactive protein, and inversely with plasma volume. Longitudinally fibrinogen levels varied positively with a variety of acute phase proteins. Kaysen et al conclude that the very high levels of fibrinogen in haemodialysis patients are secondary to the dual stimulation of inflammation and increased plasma volume. These findings are consistent with those of Giordano et al5 who showed that compared to normal subjects both albumin and fibrinogen synthesis were increased in normoalbuminemic hemodialysis patients with no evidence of inflammation (normal C-reactive protein). Plasma volume was, however, significantly increased. Can these dual effects be explained at a molecular level? The structure of the promoter regions of the rat fibrinogen genes has been well documented6, all three contain interleukin-6 (IL-6) responsive elements and it has been shown that stimulation with IL-6 results in a simultaneous, co-ordinated increase in transcription of all three genes. Similar IL-6 response elements have been found in the human B gene. In the rat it has been shown that IL-6 acts through activation of STAT3, which can, in turn, act synergistically with a glucocorticoid receptor. What about plasma volume? It is well-established that a reduction in plasma colloid osmotic pressure () is associated with an increase in transcription of both fibrinogen and albumin7. A increase or reduction in has been shown to be associated with decreased hepatocyte nuclear factor (HNF)-1 or increased HNF-4, respectively8,9. Both the albumin and fibrinogen genes have well-defined HNF-1 response elements and the hepatic specific expression of these genes is controlled primarily by HNF-16. In normal subjects an increase in plasma volume when climbing at high altitude is associated with an increase in both albumin and fibrinogen synthesis10. However, this was attributed to the physical exercise of climbing. If there is a direct causal relationship between serum fibrinogen levels and cardiovascular disease in haemodialysis patients, it would seem prudent to minimize those factors that are increasing fibrinogen synthesis. Increased blood or plasma volume is a consequence of overhydration and is associated with hypertension. Optimal correction of extracellular volume should be a priority in all haemodialysis patients. While many methods of monitoring and achieving dry weight have been proposed, dietary salt restriction receives scant attention. If inflammation is driving fibrinogen synthesis, then it is important that reversible factors are identified. Occult infectious processes such as gingivitis, parodontitis, and perirectal and urinary tract infections can cause persistent elevation of acute phase proteins. Inflammatory processes directly related to hemodialysis, including vascular access infection, inadequate water and dialysate quality, bioincompatible membranes, and inadequate reuse procedures, are potentially reversible and this may be associated with a fall in fibrinogen. Kaysen et al have therefore defined two important factors controlling fibrinogen levels in hemodialysis both of which are potentially reversible.